Belite Bio (BLTE) Current Assets (2021 - 2026)

Belite Bio's Current Assets history runs 6 years deep, the most recent figure standing at $521.9 million for Q1 2026.

• In Q1 2026, Current Assets rose 227.62% year-over-year to $521.9 million; the TTM figure through Mar 2026 stood at $521.9 million (up 227.62% YoY), while the FY2025 annual figure was $494.3 million, up 236.07% from the prior year.
• Current Assets was $521.9 million for Q1 2026 at Belite Bio, up from $494.3 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $521.9 million in Q1 2026 to a low of $38.4 million in Q1 2023.
• Historically, Current Assets has averaged $168.5 million across 5 years, with a median of $112.6 million in 2024.
• Biggest YoY gain for Current Assets was 236.07% in 2025; the steepest drop was 32.59% in 2025.
• A 5-year view of Current Assets shows it stood at $42.8 million in 2022, then soared by 110.11% to $89.9 million in 2023, then surged by 63.52% to $147.1 million in 2024, then jumped by 236.07% to $494.3 million in 2025, then rose by 5.58% to $521.9 million in 2026.
• The last three Current Assets figures came in at $521.9 million (Q1 2026), $494.3 million (Q4 2025), and $277.2 million (Q3 2025), per Business Quant data.